Home > Insider Trading > Filing (0001181431-13-017299)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891288	Questcor Pharmaceuticals Inc	QCOR	Pharmaceutical Preparations (2834)	330476164

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1223697	M Don Bailey	1300 North Kellogg Drive Suite D Anaheim CA 92807	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-03-13	20,000	$5.09	119,000	No	4	M	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Disposition	2013-03-13	20,000	$32.06	99,000	No	4	S	Indirect	Held by the Bailey 1995 Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	Held by the Bailey 1995 Family Trust
No	4	S	Indirect	Held by the Bailey 1995 Family Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2013-03-13	20,000	$0.00	20,000	$5.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
273,339		2018-02-05	No	4	M	Indirect

Footnotes

As of the date of this Form 4, the reporting person holds Questcor Pharmaceuticals, Inc. stock options to purchase 1,498,339 shares of common stock; of such amount, 1,096,672 shares are fully vested and exercisable. The reporting person also holds 391,314 shares of Questcor Pharmaceuticals, Inc. common stock, of which 292,314 shares are held directly by the reporting person, which includes the acquisition of an aggregate of 1,939 shares of common stock through the Questcor Pharmaceuticals, Inc. Amended and Restated Employee Stock Purchase Plan.
Options were granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
The option was granted on 02/06/2008 for the right to buy 500,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant, with a 12-month cliff, whereby no options vested until after the twelfth month from the date of the grant. A total of 273,339 shares remain unexercised under this option grant.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72-$32.41, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.